SlideShare a Scribd company logo
1 of 47
Presented by-
Dr. Ashutosh Kumar
AP Dept. of Orthopaedics
Rohilkhand medical collage and hospital,
Bareilly.
GOUT
Definition
• Gout is a disorder that manifests as a spectrum of clinical and pathologic features
built on a foundation of an excess body burden of uric acid, manifested in part by
hyperuricemia, which is variably defined as a serum urate level greater than
360µmol/l (6.8mg%)
• Chronic heterogeneous disorder of urate metabolism.
• Most common form of inflammatory joint disease in men aged ≥40 years
Definition
 The term gout is derived from the latin word 'guta' meaning a drop, and originally may
have referred to a drop of poison or evil humor.
 a group of diseases characterized by
hyperuricaemia and uric acid crystal
formation.
Stages
This disorder can be progressive through four
stages if undertreated
 Asymptomatic hyperuricemia
 Acute gout
 Intercritical gout
 Chronic tophaceous gout
Who May Be the Patient With Hyperuricemia and Gout?
Demographics
• Advanced age
• Male
• Postmenopausal women
Commonly Used Medications
• Diuretics
• Low-dose aspirin (eg, <325 mg)
• Cyclosporine
• Niacin
• Salicylates, Ethambutol, Pyrazinamide
• Comorbidities
• Cardiovascular disease, HTN, CKD
• DM, Dyslipidemia, metabolic syndrome
• Lifestyle
• Obesity (high BMI)
• Purine rich food- meat, kidney, liver, seafood, anchovies,
oatmeal, certain vegetables (peas, beans, lentils, mushrooms,
cauliflower, spinach), sweetbreads,
• High alcohol intake
• Frequent consumption of high-fructose corn syrup
Hyperuricemia leads to deposit of urates in the joint fluid, triggering
an inflammatory cascade
• Aggregates of uric acid crystals (tophi) in
and around joints, soft tissues, and various
organs.
• Tophus in bone leading to erosions in
some cases
• Kidney disease and stones
Clinical features
 Acute Gout:
• Acute gout is a painful condition that typically affects only one or
a few joints.
• The big toe, knee, or ankle joints are most often affected.
• Throbbing, crushing, or excruciating pain
• Joint appears warm and red. Fever may be there.
• The attack may go away in a few days, but may return from time to time.
• Additional attacks often last longer.
• After a first gouty attack, half of the people will have no symptoms. Half
of patients have another attack.
 Chronic Gout
• Signs and symptoms include:
• Joint damage
• Loss of motion in the joints
• Joint pain and other symptoms most of the time,
throughout the day
• Tophi below the skin around joints or in other places
(Tophi usually develop only after a patient has had
the disease for many years)
Advanced Chronic Tophaceous Gout
• Tophi can be seen clinically, with obvious deformity
demonstrated in hands and foot
• Tophi may be associated with bony destruction as
seen on the x-ray.
• Is characterised by massive deposits of monosodium
urate crystals (Tophi) in articular cartilage,
subchrondral bone, synovial membrane, capsule,
tendon sheaths and peri articular tissues.
• Tophi formation can also occur over eyelids, nasal
cartilage, cornea, tongue, vocal cords and penis
• The tophaceous nodules consists of
multicentric deposition of urate crystals and
intra cellular matrix and foreign body
granulomatous reaction.
• As they enlarge in size, calcify, they can
cause pressure symptoms.
• The tophi are firm yellow in colour and
occasionally discharge a chalky material.
Tophi in multiple joints
Clinical course of classic gout
Diagnostic criteria
The “Double Contour Sign” of Gout
1977 ACR Criteria for Acute gout
The presence of characteristic urate crystals in the joint fluid, or a tophus proved to contain urate crystals by chemical
means or polarized light microscopy, or the presence of 6 of the following 12 clinical, laboratory, and radiographic
phenomena:
1. More than one attack of acute arthritis
2. Maximum inflammation developed within 1 day
3. Monoarthritis attack
4. Redness observed over joints
5.First metatarsophalangeal joint painful or swollen
6.Unilateral first metatarsophalangeal joint attack
7. Unilateral tarsal joint attack
8. Tophus (proven or suspected)
9. Hyperuricemia
10.Asymmetric swelling within a joint on x ray/exam
11. Subcortical cysts without erosions on x ray
12.Joint fluid culture negative for organisms during attack
Investigations
• Plain radiographs (may be normal)
• Serum Uric acid
• Synovial fluid analyis (shows uric acid
crystals)
• BUN (blood urea nitrogen), Serum
Creatinine
• Synovial biopsy
• Uric acid – urine
Radiographic Hallmarks of Gout
Overhanging edges
Punched out lesions with sclerotic borders.
Preservation of joint space (till late)
Degenerative changes
SYNOVIAL FLUID ANALYSIS
(Polarized Light Microscopy)
• The Gold standard
• Crystals intracellular during attacks
• Needle & rod shapes
• Strong negative birefringence
BIOCHEMICAL TESTS FOR GOUT:
DifferentialDiagnosis
• Pseudogout: Chondrocalcinosis, CPPD
• Psoriatic Arthritis
• Osteoarthritis
• Rheumatoid arthritis
• Septic arthritis
• Cellulitis
Gout vs. CPPD
• Similar Acute attacks
• Different crystals under Microscope:
Rhomboid, irregular in CPPD
Gout vs RA
• Both have polyarticular, symmetric arthritis
• Tophi can be mistaken for RA nodules
Gout
TREATMENT GOALS
1. Rapidly end acute flares
2. Protect against future flares
3. Reduce chance of crystal induced inflammation
4. Prevent disease progression
5. Lower serum urate to deplete total body urate pool
6. Correct metabolic cause
Acute Flares Treatment
NSAI
DS
Colchicine
Corticosteroids
• Not as effective “late” in flare
• Contraindicated in dialysis patients
• Cautious use in :
• Renal or liver dysfunction
• Active infection
• Age > 70
• Worse glycemic control
• May need to use mod-high doses
• Interaction with
warfarin
• Contraindicated in:
• Renal
disease
• PUD
• GI bleeders
ENDING ACUTE FLARES
• Control inflammation & pain to resolve the flare
• Not a cure
• Crystals remain in joints
• Don’t try to lower serum urate during a flare
Acute Gout - Rx
NSAIDs (unless CRI, CHF, PUD, etc.)
Corticosteroids (Intra-articular if one
joint, systemic if multiple joints)
Colchicine (adjust dose in patients w/
renal insufficiency)
-Most beneficial in first 12-36 hours of an attack
-1mg initially, then 0.5mg qhr until either
symptoms relieved or GI side fx (N/V/diarrhea)
or 7mg total given
-Renal dosing:
-If Cr clearance < 50, dec. dose 50%
-If Cr clearance < 10, contraindicated.
-Indomethacin 50mg tid
-Naproxen 825mg once, then 275 q8hr
-Sulindac 200mg bid
-20-30mg/day if systemic used
Protection Against Future Flares
• Colchicine : 0.5-1.0 mg/day
• Low-dose NSAIDS
• Both decrease frequency & severity of flares
• Prevent flares with start of urate- lowering drugs
• Best with 6 months of concomitant treatment
 NSAIDS:
• Inhibits pain & inflammation.
• Inhibits urate crystal phagocytosis by decreasing the migration of granulocytes into
the inflammatory area.
• Indomethacin, Naproxen, Ketorolac.
 COLCHICINE:
• Produces its anti-inflammatory effects by binding to the intracellular protein tubulin,
preventing its polymerization leading to the inhibition of leukocyte migration into
affected area.
• Inhibits the synthesis & release of leukotrienes.
FDA-Approved
Urate-LoweringAgents
Dose RangeDrug Action
First-Line (Uricostatic)
S
Allopurinol
Febuxostat
Xanthine Oxidase
inhibitor
Xanthine Oxidase
inhibitor
100-800 mg daily (decrease
dose in renal impairment)
40-80 mg daily
econd-Line (Uricostatic)
Probenecid URAT1 and GLUT9 500-2000 mg daily (carefully
inhibitor adjust dose to 3000 mg maximum)
For Severe, Treatment-Refractory Disease (Uricostatic)
Pregloticase IV Recombinant, 8 mg IV every 2 weeks PEGylated
uricase
 Uric acid is produced by Xanthine and Hypoxanthine by Xanthine Oxidase Inhibitor.
 Uric Acid is more toxic than either xanthineor hypoxanthine.
 Allopurinol/ Febuxstat:
• Inhibits synthesis of uric acid by inhibiting xanthine oxidase enzyme
Intercritical Gout - Rx
• ,
• Education, Lifestyle/Diet modification
Pharmacotherapy modification
• Allopurinol therapy if:
-Recurrent attacks despite diet chg/etc.
-Hx of nephrolithiasis
-Serum creatinine > 2.0
-Serum uric acid > 11.0
-24 hr urine uric acid > 800mg/dL
-Tophi present
• Probenecid if:
- Recurrent attacks and 24hr urine uric acid <
800mg/dL
Allopurinol toxicity?
Colchicine
Prevent Disease Progression
• Lower urate to < 6 mg/dl :
• Depletes
Total body urate pool Deposited
crystals
• Treatment is lifelong & continuous
• Drug choices : Uricosuric agents
Xanthine oxidase inhibitor
Asymptomatic Hyperuricemia
• Indications for Rx include:
 24hr Urinary Uric Acid Excretion > 1100mg
 Serum uric acid: Men > 13mg/dL, Women > 10mg/dL
 Nephrolithiasis
 Any hx of symptoms of gout, especially w/ worsening renal function
 Presence of gouty tophi in bone or soft tissues
 Radiographic signs of gouty arthritis
 Impending chemotherapy or radiotherapy for leukemia or lymphoma
Which Drug to use?
• Base choice on above considerations & whether patient is an overproducer or
underexcretor.
• Need to get a 24-hr. urine for urate excretion:
< 700 --- underexcretor (uricosuric)
> 700 --- overproducer (allopurinol)
• 90% of the patients are underexcretors.
PREVENTION
Maintain the concentration of Uric Acid level within the normal range.
 Drinking Plenty of Water.
 Balance your weight with proper diet and exercise
 Avoid purine rich foods
 Reducing alcohol consumption
 Avoid Diuretic Drugs.
 Foods known to decrease the occurrence of gout include dairy, foods high in
potassium, black cherry juice, blueberries and lemon juice.
 Immediately treating gout will not allow it worse.
Newer Drugs
 URICASE ENZYMES:
• Catabolize urate to allantoin: More soluble, excretable form
• Currently approved for hyperuricemia in tumor lysis syndrome
• Some concerns: fatal immunogenicity & unknown long-term effects
Gout

More Related Content

What's hot

What's hot (20)

Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Gout
GoutGout
Gout
 
Osteoarthritis 2021 Updated Guidelines
Osteoarthritis 2021 Updated GuidelinesOsteoarthritis 2021 Updated Guidelines
Osteoarthritis 2021 Updated Guidelines
 
Gout
GoutGout
Gout
 
Gout
GoutGout
Gout
 
Gout and Hyperuricemia
Gout and HyperuricemiaGout and Hyperuricemia
Gout and Hyperuricemia
 
Gout (1)
Gout (1)Gout (1)
Gout (1)
 
Osteoarthritis pathophysiology & updated management
Osteoarthritis pathophysiology & updated managementOsteoarthritis pathophysiology & updated management
Osteoarthritis pathophysiology & updated management
 
Gouty arthritis
Gouty arthritisGouty arthritis
Gouty arthritis
 
Crystal arthropathies gout &amp; pseudogout
Crystal arthropathies  gout &amp; pseudogoutCrystal arthropathies  gout &amp; pseudogout
Crystal arthropathies gout &amp; pseudogout
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Monoarthritis
MonoarthritisMonoarthritis
Monoarthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Approach to the patient with arthritis
Approach to the patient with arthritisApproach to the patient with arthritis
Approach to the patient with arthritis
 
Gout
GoutGout
Gout
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Gout
GoutGout
Gout
 
Gout and pseudogout
Gout and pseudogoutGout and pseudogout
Gout and pseudogout
 
Approach to case of arthritis
Approach to case of arthritisApproach to case of arthritis
Approach to case of arthritis
 
GOUT
GOUTGOUT
GOUT
 

Similar to Gout

Gouty Arthritis updates by arman 420.pptx
Gouty Arthritis updates by arman 420.pptxGouty Arthritis updates by arman 420.pptx
Gouty Arthritis updates by arman 420.pptx
Azadov1
 

Similar to Gout (20)

Gouty Arthritis
Gouty ArthritisGouty Arthritis
Gouty Arthritis
 
gout.pptx
gout.pptxgout.pptx
gout.pptx
 
Gouty arthritis
Gouty arthritisGouty arthritis
Gouty arthritis
 
IMSK-_Gout.pdf
IMSK-_Gout.pdfIMSK-_Gout.pdf
IMSK-_Gout.pdf
 
Gouty Arthritis
Gouty ArthritisGouty Arthritis
Gouty Arthritis
 
GOUT
GOUTGOUT
GOUT
 
Gout arthritis - comprehensive ppt
Gout arthritis - comprehensive pptGout arthritis - comprehensive ppt
Gout arthritis - comprehensive ppt
 
GOUTY ARTHRITIS
GOUTY ARTHRITISGOUTY ARTHRITIS
GOUTY ARTHRITIS
 
Gout
GoutGout
Gout
 
Gouty Arthritis updates by arman 420.pptx
Gouty Arthritis updates by arman 420.pptxGouty Arthritis updates by arman 420.pptx
Gouty Arthritis updates by arman 420.pptx
 
2009 gout pharmacology
2009 gout pharmacology2009 gout pharmacology
2009 gout pharmacology
 
Gout and gouty arthritis.pptx
Gout and gouty arthritis.pptxGout and gouty arthritis.pptx
Gout and gouty arthritis.pptx
 
16 Gout.pptx
16 Gout.pptx16 Gout.pptx
16 Gout.pptx
 
Gout
GoutGout
Gout
 
Gout - Clinical features , diagnosis and management
Gout - Clinical features , diagnosis and managementGout - Clinical features , diagnosis and management
Gout - Clinical features , diagnosis and management
 
Gout
GoutGout
Gout
 
Hyperuricemia and Gout
Hyperuricemia and GoutHyperuricemia and Gout
Hyperuricemia and Gout
 
Uric acid metabolism and Gout
Uric acid metabolism and GoutUric acid metabolism and Gout
Uric acid metabolism and Gout
 
Rheumatology.pdf
Rheumatology.pdfRheumatology.pdf
Rheumatology.pdf
 
Rheumatoid arthritis and gout
Rheumatoid arthritis  and goutRheumatoid arthritis  and gout
Rheumatoid arthritis and gout
 

More from Ashutosh Kumar

Fracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutoshFracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutosh
Ashutosh Kumar
 
Traumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutoshTraumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutosh
Ashutosh Kumar
 
General outline of musculoskeletal tuberculosis by dr ashutosh
General outline of musculoskeletal tuberculosis by dr ashutoshGeneral outline of musculoskeletal tuberculosis by dr ashutosh
General outline of musculoskeletal tuberculosis by dr ashutosh
Ashutosh Kumar
 
Humerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutoshHumerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutosh
Ashutosh Kumar
 
Distal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutoshDistal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutosh
Ashutosh Kumar
 
Distal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutoshDistal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutosh
Ashutosh Kumar
 
Distal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutoshDistal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutosh
Ashutosh Kumar
 

More from Ashutosh Kumar (15)

Fracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutoshFracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutosh
 
Tuberculosis of knee by dr ashutosh
Tuberculosis of knee by dr ashutoshTuberculosis of knee by dr ashutosh
Tuberculosis of knee by dr ashutosh
 
Traumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutoshTraumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutosh
 
Tb hip
Tb hipTb hip
Tb hip
 
Pottsspine &amp; paraplegia by dr ashutosh
Pottsspine &amp; paraplegia by dr ashutoshPottsspine &amp; paraplegia by dr ashutosh
Pottsspine &amp; paraplegia by dr ashutosh
 
Peripheral nerve injury by dr ashutosh
Peripheral nerve injury by dr ashutoshPeripheral nerve injury by dr ashutosh
Peripheral nerve injury by dr ashutosh
 
Humerusfracture 170427173809-converted
Humerusfracture 170427173809-convertedHumerusfracture 170427173809-converted
Humerusfracture 170427173809-converted
 
General outline of musculoskeletal tuberculosis by dr ashutosh
General outline of musculoskeletal tuberculosis by dr ashutoshGeneral outline of musculoskeletal tuberculosis by dr ashutosh
General outline of musculoskeletal tuberculosis by dr ashutosh
 
Humerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutoshHumerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutosh
 
Fracture shaft of femur by dr ashutosh
Fracture shaft of femur by dr ashutoshFracture shaft of femur by dr ashutosh
Fracture shaft of femur by dr ashutosh
 
Distal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutoshDistal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutosh
 
Distal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutoshDistal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutosh
 
Distal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutoshDistal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutosh
 
Ankylosing spondylitis by dr ashutosh
Ankylosing spondylitis by dr ashutoshAnkylosing spondylitis by dr ashutosh
Ankylosing spondylitis by dr ashutosh
 
Acute pyogenic arthritis by dr ashutosh
Acute pyogenic arthritis by dr ashutoshAcute pyogenic arthritis by dr ashutosh
Acute pyogenic arthritis by dr ashutosh
 

Recently uploaded

Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 

Recently uploaded (20)

PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 

Gout

  • 1. Presented by- Dr. Ashutosh Kumar AP Dept. of Orthopaedics Rohilkhand medical collage and hospital, Bareilly. GOUT
  • 2. Definition • Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia, which is variably defined as a serum urate level greater than 360µmol/l (6.8mg%) • Chronic heterogeneous disorder of urate metabolism. • Most common form of inflammatory joint disease in men aged ≥40 years
  • 3. Definition  The term gout is derived from the latin word 'guta' meaning a drop, and originally may have referred to a drop of poison or evil humor.  a group of diseases characterized by hyperuricaemia and uric acid crystal formation.
  • 4. Stages This disorder can be progressive through four stages if undertreated  Asymptomatic hyperuricemia  Acute gout  Intercritical gout  Chronic tophaceous gout
  • 5. Who May Be the Patient With Hyperuricemia and Gout? Demographics • Advanced age • Male • Postmenopausal women Commonly Used Medications • Diuretics • Low-dose aspirin (eg, <325 mg) • Cyclosporine • Niacin • Salicylates, Ethambutol, Pyrazinamide • Comorbidities • Cardiovascular disease, HTN, CKD • DM, Dyslipidemia, metabolic syndrome • Lifestyle • Obesity (high BMI) • Purine rich food- meat, kidney, liver, seafood, anchovies, oatmeal, certain vegetables (peas, beans, lentils, mushrooms, cauliflower, spinach), sweetbreads, • High alcohol intake • Frequent consumption of high-fructose corn syrup
  • 6.
  • 7. Hyperuricemia leads to deposit of urates in the joint fluid, triggering an inflammatory cascade
  • 8.
  • 9. • Aggregates of uric acid crystals (tophi) in and around joints, soft tissues, and various organs. • Tophus in bone leading to erosions in some cases • Kidney disease and stones
  • 10.
  • 11. Clinical features  Acute Gout: • Acute gout is a painful condition that typically affects only one or a few joints. • The big toe, knee, or ankle joints are most often affected. • Throbbing, crushing, or excruciating pain • Joint appears warm and red. Fever may be there. • The attack may go away in a few days, but may return from time to time. • Additional attacks often last longer. • After a first gouty attack, half of the people will have no symptoms. Half of patients have another attack.
  • 12.
  • 13.
  • 14.  Chronic Gout • Signs and symptoms include: • Joint damage • Loss of motion in the joints • Joint pain and other symptoms most of the time, throughout the day • Tophi below the skin around joints or in other places (Tophi usually develop only after a patient has had the disease for many years)
  • 15. Advanced Chronic Tophaceous Gout • Tophi can be seen clinically, with obvious deformity demonstrated in hands and foot • Tophi may be associated with bony destruction as seen on the x-ray. • Is characterised by massive deposits of monosodium urate crystals (Tophi) in articular cartilage, subchrondral bone, synovial membrane, capsule, tendon sheaths and peri articular tissues. • Tophi formation can also occur over eyelids, nasal cartilage, cornea, tongue, vocal cords and penis
  • 16. • The tophaceous nodules consists of multicentric deposition of urate crystals and intra cellular matrix and foreign body granulomatous reaction. • As they enlarge in size, calcify, they can cause pressure symptoms. • The tophi are firm yellow in colour and occasionally discharge a chalky material.
  • 18. Clinical course of classic gout
  • 20. The “Double Contour Sign” of Gout
  • 21. 1977 ACR Criteria for Acute gout The presence of characteristic urate crystals in the joint fluid, or a tophus proved to contain urate crystals by chemical means or polarized light microscopy, or the presence of 6 of the following 12 clinical, laboratory, and radiographic phenomena: 1. More than one attack of acute arthritis 2. Maximum inflammation developed within 1 day 3. Monoarthritis attack 4. Redness observed over joints 5.First metatarsophalangeal joint painful or swollen 6.Unilateral first metatarsophalangeal joint attack 7. Unilateral tarsal joint attack 8. Tophus (proven or suspected) 9. Hyperuricemia 10.Asymmetric swelling within a joint on x ray/exam 11. Subcortical cysts without erosions on x ray 12.Joint fluid culture negative for organisms during attack
  • 22. Investigations • Plain radiographs (may be normal) • Serum Uric acid • Synovial fluid analyis (shows uric acid crystals) • BUN (blood urea nitrogen), Serum Creatinine • Synovial biopsy • Uric acid – urine
  • 23. Radiographic Hallmarks of Gout Overhanging edges Punched out lesions with sclerotic borders. Preservation of joint space (till late) Degenerative changes
  • 24. SYNOVIAL FLUID ANALYSIS (Polarized Light Microscopy) • The Gold standard • Crystals intracellular during attacks • Needle & rod shapes • Strong negative birefringence
  • 26. DifferentialDiagnosis • Pseudogout: Chondrocalcinosis, CPPD • Psoriatic Arthritis • Osteoarthritis • Rheumatoid arthritis • Septic arthritis • Cellulitis
  • 27. Gout vs. CPPD • Similar Acute attacks • Different crystals under Microscope: Rhomboid, irregular in CPPD
  • 28. Gout vs RA • Both have polyarticular, symmetric arthritis • Tophi can be mistaken for RA nodules
  • 29. Gout
  • 30. TREATMENT GOALS 1. Rapidly end acute flares 2. Protect against future flares 3. Reduce chance of crystal induced inflammation 4. Prevent disease progression 5. Lower serum urate to deplete total body urate pool 6. Correct metabolic cause
  • 31. Acute Flares Treatment NSAI DS Colchicine Corticosteroids • Not as effective “late” in flare • Contraindicated in dialysis patients • Cautious use in : • Renal or liver dysfunction • Active infection • Age > 70 • Worse glycemic control • May need to use mod-high doses • Interaction with warfarin • Contraindicated in: • Renal disease • PUD • GI bleeders
  • 32. ENDING ACUTE FLARES • Control inflammation & pain to resolve the flare • Not a cure • Crystals remain in joints • Don’t try to lower serum urate during a flare
  • 33. Acute Gout - Rx NSAIDs (unless CRI, CHF, PUD, etc.) Corticosteroids (Intra-articular if one joint, systemic if multiple joints) Colchicine (adjust dose in patients w/ renal insufficiency) -Most beneficial in first 12-36 hours of an attack -1mg initially, then 0.5mg qhr until either symptoms relieved or GI side fx (N/V/diarrhea) or 7mg total given -Renal dosing: -If Cr clearance < 50, dec. dose 50% -If Cr clearance < 10, contraindicated. -Indomethacin 50mg tid -Naproxen 825mg once, then 275 q8hr -Sulindac 200mg bid -20-30mg/day if systemic used
  • 34. Protection Against Future Flares • Colchicine : 0.5-1.0 mg/day • Low-dose NSAIDS • Both decrease frequency & severity of flares • Prevent flares with start of urate- lowering drugs • Best with 6 months of concomitant treatment
  • 35.  NSAIDS: • Inhibits pain & inflammation. • Inhibits urate crystal phagocytosis by decreasing the migration of granulocytes into the inflammatory area. • Indomethacin, Naproxen, Ketorolac.  COLCHICINE: • Produces its anti-inflammatory effects by binding to the intracellular protein tubulin, preventing its polymerization leading to the inhibition of leukocyte migration into affected area. • Inhibits the synthesis & release of leukotrienes.
  • 36. FDA-Approved Urate-LoweringAgents Dose RangeDrug Action First-Line (Uricostatic) S Allopurinol Febuxostat Xanthine Oxidase inhibitor Xanthine Oxidase inhibitor 100-800 mg daily (decrease dose in renal impairment) 40-80 mg daily econd-Line (Uricostatic) Probenecid URAT1 and GLUT9 500-2000 mg daily (carefully inhibitor adjust dose to 3000 mg maximum) For Severe, Treatment-Refractory Disease (Uricostatic) Pregloticase IV Recombinant, 8 mg IV every 2 weeks PEGylated uricase
  • 37.  Uric acid is produced by Xanthine and Hypoxanthine by Xanthine Oxidase Inhibitor.  Uric Acid is more toxic than either xanthineor hypoxanthine.
  • 38.  Allopurinol/ Febuxstat: • Inhibits synthesis of uric acid by inhibiting xanthine oxidase enzyme
  • 39. Intercritical Gout - Rx • , • Education, Lifestyle/Diet modification Pharmacotherapy modification • Allopurinol therapy if: -Recurrent attacks despite diet chg/etc. -Hx of nephrolithiasis -Serum creatinine > 2.0 -Serum uric acid > 11.0 -24 hr urine uric acid > 800mg/dL -Tophi present • Probenecid if: - Recurrent attacks and 24hr urine uric acid < 800mg/dL Allopurinol toxicity? Colchicine
  • 40. Prevent Disease Progression • Lower urate to < 6 mg/dl : • Depletes Total body urate pool Deposited crystals • Treatment is lifelong & continuous • Drug choices : Uricosuric agents Xanthine oxidase inhibitor
  • 41. Asymptomatic Hyperuricemia • Indications for Rx include:  24hr Urinary Uric Acid Excretion > 1100mg  Serum uric acid: Men > 13mg/dL, Women > 10mg/dL  Nephrolithiasis  Any hx of symptoms of gout, especially w/ worsening renal function  Presence of gouty tophi in bone or soft tissues  Radiographic signs of gouty arthritis  Impending chemotherapy or radiotherapy for leukemia or lymphoma
  • 42. Which Drug to use? • Base choice on above considerations & whether patient is an overproducer or underexcretor. • Need to get a 24-hr. urine for urate excretion: < 700 --- underexcretor (uricosuric) > 700 --- overproducer (allopurinol) • 90% of the patients are underexcretors.
  • 43. PREVENTION Maintain the concentration of Uric Acid level within the normal range.  Drinking Plenty of Water.  Balance your weight with proper diet and exercise  Avoid purine rich foods  Reducing alcohol consumption  Avoid Diuretic Drugs.
  • 44.  Foods known to decrease the occurrence of gout include dairy, foods high in potassium, black cherry juice, blueberries and lemon juice.  Immediately treating gout will not allow it worse.
  • 45.
  • 46. Newer Drugs  URICASE ENZYMES: • Catabolize urate to allantoin: More soluble, excretable form • Currently approved for hyperuricemia in tumor lysis syndrome • Some concerns: fatal immunogenicity & unknown long-term effects